Pineau D - Search Results

1

Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.

Moreau P, Robillard N, Avet-Loiseau H, Pineau D, Morineau N, Milpied N, Harousseau JL, Bataille R. Moreau P, et al. Among authors: pineau d. Haematologica. 2004 May;89(5):547-51. Haematologica. 2004. PMID: 15136217

2

CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.

Robillard N, Avet-Loiseau H, Garand R, Moreau P, Pineau D, Rapp MJ, Harousseau JL, Bataille R. Robillard N, et al. Among authors: pineau d. Blood. 2003 Aug 1;102(3):1070-1. doi: 10.1182/blood-2002-11-3333. Epub 2003 Apr 17. Blood. 2003. PMID: 12702507 Free article.

3

Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products.

Hermouet S, Niaussat AE, Briec A, Pineau D, Robillard N, Bataille R, Milpied N, Harousseau JL, Mahé B. Hermouet S, et al. Among authors: pineau d. Hematol Cell Ther. 1997 Dec;39(6):317-25. doi: 10.1007/s00282-997-0317-8. Hematol Cell Ther. 1997. PMID: 9497891

4

CD28, a marker associated with tumoral expansion in multiple myeloma.

Robillard N, Jego G, Pellat-Deceunynck C, Pineau D, Puthier D, Mellerin MP, Barillé S, Rapp MJ, Harousseau JL, Amiot M, Bataille R. Robillard N, et al. Among authors: pineau d. Clin Cancer Res. 1998 Jun;4(6):1521-6. Clin Cancer Res. 1998. PMID: 9626472

5

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma.

Pellat-Deceunynck C, Barillé S, Jego G, Puthier D, Robillard N, Pineau D, Rapp MJ, Harousseau JL, Amiot M, Bataille R. Pellat-Deceunynck C, et al. Among authors: pineau d. Leukemia. 1998 Dec;12(12):1977-82. doi: 10.1038/sj.leu.2401211. Leukemia. 1998. PMID: 9844928

6

Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells.

Jego G, Robillard N, Puthier D, Amiot M, Accard F, Pineau D, Harousseau JL, Bataille R, Pellat-Deceunynck C. Jego G, et al. Among authors: pineau d. Blood. 1999 Jul 15;94(2):701-12. Blood. 1999. PMID: 10397737 Free article.

7

CD130 rather than CD126 expression is associated with disease activity in multiple myeloma.

Barillé S, Thabard W, Robillard N, Moreau P, Pineau D, Harousseau JL, Bataille R, Amiot M. Barillé S, et al. Among authors: pineau d. Br J Haematol. 1999 Aug;106(2):532-5. doi: 10.1046/j.1365-2141.1999.01563.x. Br J Haematol. 1999. PMID: 10460618 Free article.

8

In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients.

Mahe B, Menard A, Accard F, Pineau D, Robillard N, Hermouet S. Mahe B, et al. Among authors: pineau d. Nouv Rev Fr Hematol (1978). 1995;37(6):335-41. Nouv Rev Fr Hematol (1978). 1995. PMID: 8907629 Clinical Trial.

9

Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.

Dobo I, Pineau D, Robillard N, Geneviève F, Piard N, Zandecki M, Hermouet S. Dobo I, et al. Among authors: pineau d. J Hematother Stem Cell Res. 2003 Oct;12(5):543-51. doi: 10.1089/152581603322448259. J Hematother Stem Cell Res. 2003. PMID: 14594511

10

Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses.

Dobo I, Robillard N, Pineau D, Geneviève F, Piard N, Rapp MJ, Boasson M, Zandecki M, Hermouet S. Dobo I, et al. Among authors: pineau d. Ann Hematol. 2001 Nov;80(11):639-46. doi: 10.1007/s002770100365. Ann Hematol. 2001. PMID: 11757722 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters